Grown Rogue International (GRUSF) Net Equity Issued and Repurchased (2019)

Grown Rogue International's (GRUSF) quarterly Net Equity Issued and Repurchased came in at -$200567.0 in Q1 2019.

Grown Rogue International (GRUSF) Net Equity Issued and Repurchased (2019) Analysis & Trends

Grown Rogue International's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at -$200567.0 for Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn -

Historic Data

Download Data
DateValue
Jan 31, 2019 -200,567.00
Jan 31, 2019 -200,567.00